Skip to main content

Table 1 Overall characteristics of mutation carriers

From: LMNA mutations in Polish patients with dilated cardiomyopathy: prevalence, clinical characteristics, and in vitro studies

Variable

Clinical data

Number of mutation carriers (%)

25

Type of mutation

6-missense/19-nonsense

Male sex (%)

17 (68)

Number of asymptomatic carriers; mean age ± SD

5; 28,2 ± 7,1 years

Mean age at the onset of symptoms ± SD

29,9 ± 13,3 years

Conduction disease/AV block I, II

18/25 (72%)/ 13/25 (52%)

Atrial fibrillation (%)

9/25 (36%)

Complex ventricular arrhythmia (VT/VF)

15/25 (60%)

Heart failure, n (%), mean age ± SD

9/25 (36%), 36.9 ± 11.3 years

Pacemaker implantations (%)

8 (32%)

Cardioverter-defibrillator implantations (%)

14 (56%)

Adequate ICD discharges, n (%); time to first intervention

4 (28.6%); 1.8-20 months

Subjects with CPK measured; elevated CPK > 308U/l (%)

23; 8 (34.8%)

Heart transplantation (%), mean age ± SD

6/25 (24%), 39,2 ± 9.9 years